RA Capital Management - KALA PHARMACEUTICALS INC ownership

KALA PHARMACEUTICALS INC's ticker is KALA and the CUSIP is 483119103. A total of 109 filers reported holding KALA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 3.37 and the average weighting 0.0%.

Quarter-by-quarter ownership
RA Capital Management ownership history of KALA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$15,007,000
+14.1%
10,874,6130.0%0.33%
+40.9%
Q4 2021$13,158,000
-53.8%
10,874,6130.0%0.23%
-41.3%
Q3 2021$28,491,000
-50.6%
10,874,6130.0%0.40%
-57.3%
Q2 2021$57,635,000
-21.4%
10,874,6130.0%0.92%
-16.3%
Q1 2021$73,295,000
-0.6%
10,874,6130.0%1.10%
+7.2%
Q4 2020$73,730,000
-9.6%
10,874,6130.0%1.03%
-30.9%
Q3 2020$81,560,000
-28.6%
10,874,6130.0%1.49%
-33.0%
Q2 2020$114,292,000
+19.6%
10,874,6130.0%2.23%
-26.2%
Q1 2020$95,588,000
+470.9%
10,874,613
+139.7%
3.02%
+494.3%
Q4 2019$16,743,000
-3.0%
4,537,4780.0%0.51%
-50.6%
Q3 2019$17,265,000
-40.4%
4,537,4780.0%1.03%
-33.8%
Q2 2019$28,949,000
-22.9%
4,537,4780.0%1.55%
-4.0%
Q1 2019$37,525,000
+69.1%
4,537,4780.0%1.62%
+25.2%
Q4 2018$22,188,000
+6.4%
4,537,478
+114.7%
1.29%
+15.9%
Q3 2018$20,858,000
-28.1%
2,113,2360.0%1.12%
-40.8%
Q2 2018$29,015,000
-13.3%
2,113,2360.0%1.88%
-26.5%
Q1 2018$33,453,000
-14.4%
2,113,2360.0%2.56%
-21.6%
Q4 2017$39,074,000
-19.0%
2,113,2360.0%3.27%
-25.0%
Q3 2017$48,266,0002,113,2364.36%
Other shareholders
KALA PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Parallel Advisors, LLC 1$90.00%
View complete list of KALA PHARMACEUTICALS INC shareholders